These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12714585)

  • 21. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
    Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
    Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
    Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells.
    Van de Sande T; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Cancer Res; 2002 Feb; 62(3):642-6. PubMed ID: 11830512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibited.
    Molton SA; Todd DE; Cook SJ
    Oncogene; 2003 Jul; 22(30):4690-701. PubMed ID: 12879014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation.
    Park HS; Kim MS; Huh SH; Park J; Chung J; Kang SS; Choi EJ
    J Biol Chem; 2002 Jan; 277(4):2573-8. PubMed ID: 11707464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essential role of mitogen-activated protein kinase pathway and c-Jun induction in epidermal growth factor-induced gene expression of human 12-lipoxygenase.
    Chen BK; Kung HC; Tsai TY; Chang WC
    Mol Pharmacol; 2000 Jan; 57(1):153-61. PubMed ID: 10617690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis.
    Willaime-Morawek S; Brami-Cherrier K; Mariani J; Caboche J; Brugg B
    Neuroscience; 2003; 119(2):387-97. PubMed ID: 12770554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells.
    Serova M; Ghoul A; Benhadji KA; Faivre S; Le Tourneau C; Cvitkovic E; Lokiec F; Lord J; Ogbourne SM; Calvo F; Raymond E
    Mol Cancer Ther; 2008 Apr; 7(4):915-22. PubMed ID: 18413805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter.
    Pore N; Liu S; Haas-Kogan DA; O'Rourke DM; Maity A
    Cancer Res; 2003 Jan; 63(1):236-41. PubMed ID: 12517803
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
    Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
    [No Abstract]   [Full Text] [Related]  

  • 32. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
    Mansouri A; Ridgway LD; Korapati AL; Zhang Q; Tian L; Wang Y; Siddik ZH; Mills GB; Claret FX
    J Biol Chem; 2003 May; 278(21):19245-56. PubMed ID: 12637505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase.
    Wang X; Gjörloff-Wingren A; Saxena M; Pathan N; Reed JC; Mustelin T
    J Immunol; 2000 Feb; 164(4):1934-9. PubMed ID: 10657643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein.
    Mehrhof FB; Müller FU; Bergmann MW; Li P; Wang Y; Schmitz W; Dietz R; von Harsdorf R
    Circulation; 2001 Oct; 104(17):2088-94. PubMed ID: 11673351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH(2)-terminal protein kinase-related cell death pathway.
    Bae MA; Pie JE; Song BJ
    Mol Pharmacol; 2001 Oct; 60(4):847-56. PubMed ID: 11562448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets.
    Aikin R; Maysinger D; Rosenberg L
    Endocrinology; 2004 Oct; 145(10):4522-31. PubMed ID: 15242986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
    Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
    J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
    Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells.
    Matsumoto J; Kaneda M; Tada M; Hamada J; Okushiba S; Kondo S; Katoh H; Moriuchi T
    Jpn J Cancer Res; 2002 Dec; 93(12):1317-26. PubMed ID: 12495471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway.
    Rousse S; Lallemand F; Montarras D; Pinset C; Mazars A; Prunier C; Atfi A; Dubois C
    J Biol Chem; 2001 Dec; 276(50):46961-7. PubMed ID: 11598109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.